|
Re: early report imo
|
6
|
Resverlogix Corp.
|
Jul 03, 2022 03:28PM
|
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
6
|
Resverlogix Corp.
|
Apr 14, 2021 10:06AM
|
|
Re: RVX on local Calgary CTV at 5 and 6pm on 11 March
|
6
|
Resverlogix Corp.
|
Mar 12, 2021 10:26AM
|
|
On Yahoo
|
6
|
Resverlogix Corp.
|
Oct 31, 2019 01:33PM
|
|
Not out of the woods yet with COVID-19
|
6
|
Resverlogix Corp.
|
Feb 18, 2022 07:48AM
|
|
Re: Don's latest presentation - Pfizer's SGLT2 is Steglatro (Ertugliflozin)
|
6
|
Resverlogix Corp.
|
Sep 23, 2020 08:24AM
|
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
6
|
Resverlogix Corp.
|
Jan 18, 2022 09:52AM
|
|
57th ERA-EDTA Congress Abstracts
|
6
|
Resverlogix Corp.
|
Jun 08, 2020 05:04AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 05:37AM
|
|
Zenith-Oncology Pipeline
|
6
|
Zenith Epigenetics
|
Mar 16, 2021 08:18AM
|
|
Re: Congratulations To.....
|
6
|
Resverlogix Corp.
|
Dec 11, 2019 05:22AM
|
|
Re: great,good,bad,ugly or so so??
|
6
|
Resverlogix Corp.
|
May 19, 2022 07:18AM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
5
|
Resverlogix Corp.
|
Mar 18, 2022 10:33AM
|
|
Re: CityNews cover
|
5
|
Resverlogix Corp.
|
Jan 31, 2022 02:29PM
|
|
Re: To our scientist
|
5
|
Resverlogix Corp.
|
Dec 05, 2020 10:03AM
|
|
Re: Hello
|
5
|
Resverlogix Corp.
|
Feb 16, 2022 03:41PM
|
|
Re: Apropos AGM
|
5
|
Resverlogix Corp.
|
Jun 08, 2022 06:49PM
|
|
Re: I would rather,...
|
5
|
Resverlogix Corp.
|
Dec 07, 2019 10:11AM
|
|
Re: Come on RVX ... ONE TIME
|
5
|
Resverlogix Corp.
|
Oct 09, 2019 10:36AM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
5
|
Resverlogix Corp.
|
Oct 04, 2023 09:03AM
|
